Reduction in Tedizolid Plasma Exposure among End-Stage Renal Disease Patients Undergoing Dialysis Is Explained by Variations in Ideal Body Weight

Por Flanagan, Shawn, Prokocimer, Philippe
Publicado no Antimicrob Agents Chemother (2016)

264 Results of the Surveillance of Tedizolid Activity and Resistance (STAR) Program: In Vitro Susceptibility of Gram-Positive Clinical Isolates Collected in 2013 From the United St...

Por Bien, Paul, Prokocimer, Philippe
Publicado no Open Forum Infect Dis (2014)

Comparison of Digital Planimetry and Ruler Technique To Measure ABSSSI Lesion Sizes in the ESTABLISH–1 Study

Por Bien, Paul, De Anda, Carisa, Prokocimer, Philippe
Publicado em 2014

Pharmacokinetics of Tedizolid and Pseudoephedrine Administered Alone or in Combination in Healthy Volunteers

Por Flanagan, Shawn, Minassian, Sonia L., Prokocimer, Philippe
Publicado no J Clin Med (2018)

262 Effect of NSAID/Corticosteroid Use on the Efficacy of Tedizolid in Acute Bacterial Skin and Skin Structure Infections: Pooled Data From the Phase 3 ESTABLISH-1 and ESTABLISH-2...

Por Sandison, Taylor, De Anda, Carisa, Das, Anita, Prokocimer, Philippe
Publicado no Open Forum Infect Dis (2014)

Platelet Profile in Patients with Acute Bacterial Skin and Skin Structure Infections Receiving Tedizolid or Linezolid: Findings from the Phase 3 ESTABLISH Clinical Trials

Por Lodise, Thomas P., Fang, Edward, Minassian, Sonia L., Prokocimer, Philippe G.
Publicado no Antimicrob Agents Chemother (2014)

In Vitro Activity and Microbiological Efficacy of Tedizolid (TR-700) against Gram-Positive Clinical Isolates from a Phase 2 Study of Oral Tedizolid Phosphate (TR-701) in Patients w...

Por Prokocimer, Philippe, Bien, Paul, DeAnda, Carisa, Pillar, Chris M., Bartizal, Ken
Publicado em 2012

Clinical Response of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections by Severity Measure Using a Pooled Analysis from Two Phase 3 Double-Blind Tria...

Por Sandison, Taylor, De Anda, Carisa, Fang, Edward, Das, Anita F., Prokocimer, Philippe
Publicado no Antimicrob Agents Chemother (2017)

Single- and Multiple-Dose Pharmacokinetics and Absolute Bioavailability of Tedizolid

Por Flanagan, Shawn, Fang, Edward, Muñoz, Kelly A, Minassian, Sonia L, Prokocimer, Philippe G
Publicado no Pharmacotherapy (2014)

Skin and soft tissue concentrations of tedizolid (formerly torezolid), a novel oxazolidinone, following a single oral dose in healthy volunteers

Por Sahre, Martina, Sabarinath, Sreedharan, Grant, Maria, Seubert, Christoph, DeAnda, Carisa, Prokocimer, Philippe, Derendorf, Hartmut
Publicado em 2012

Pharmacokinetics of Tedizolid Following Oral Administration: Single and Multiple Dose, Effect of Food, and Comparison of Two Solid Forms of the Prodrug

Por Flanagan, Shawn D, Bien, Paul A, Muñoz, Kelly A, Minassian, Sonia L, Prokocimer, Philippe G
Publicado no Pharmacotherapy (2013)

Analysis of the Phase 3 ESTABLISH Trials of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections

Por Shorr, Andrew F., Lodise, Thomas P., Corey, G. Ralph, De Anda, Carisa, Fang, Edward, Das, Anita F., Prokocimer, Philippe
Publicado no Antimicrob Agents Chemother (2015)

Nonclinical and Pharmacokinetic Assessments To Evaluate the Potential of Tedizolid and Linezolid To Affect Mitochondrial Function

Por Flanagan, Shawn, McKee, Edward E., Das, Debaditya, Tulkens, Paul M., Hosako, Hiromi, Fiedler-Kelly, Jill, Passarell, Julie, Radovsky, Ann, Prokocimer, Philippe
Publicado no Antimicrob Agents Chemother (2014)